Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein C pseudogene 6 (HNRNPCP6)

Target
HNRNPCP6
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA)
01

Overview

HNRNPCP6, or heterogeneous nuclear ribonucleoprotein C pseudogene 6, is classified as a processed pseudogene in the human genome[4]. It is highly homologous to the parental gene encoding heterogeneous nuclear ribonucleoprotein C (HNRNPC), but it typically does not encode a functional protein due to disruptive mutations or lack of regulatory elements required for expression. Like other pseudogenes, HNRNPCP6 may influence gene expression at the RNA level, for instance, by acting as a competitive endogenous RNA (ceRNA) that sequesters microRNAs or RNA-binding proteins, or occasionally by producing regulatory RNA species[2]. Though the biological significance of many pseudogenes remains unclear, increasing evidence suggests some pseudogenes play regulatory roles in cancer and other diseases by modulating the expression of parental or related genes[2]. However, for HNRNPCP6 itself, there is currently no direct evidence for a functional role or validated disease mechanism.

Other names
HNRNPCP6heterogeneous nuclear ribonucleoprotein C (C1/C2) pseudogene
02

Biological functions

Regulator of gene expression by acting as a competitive endogenous RNA (ceRNA)potential source of regulatory small RNAsmay affect splicing of other molecules by interacting with RNA-binding proteins
03

Disease associations

Possibly implicated as a biomarker in disease (GeneCards and other resources associate this pseudogene nominally with "Atrial fibrillation" but without mechanistic support)Extensive roles are described for related pseudogenes in cancer; there is no specific evidence HNRNPCP6 itself has a mechanistic disease role beyond association

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein C pseudogene 6 (HNRNPCP6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein C pseudogene 6 (HNRNPCP6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call